| 查看: 1032 | 回复: 5 | ||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | ||
[求助]
质量标准求助 已有2人参与
|
||
| 碘海醇注射液的质量标准 Iohexol Injection, BP 、EP |
回复此楼» 猜你喜欢
申博自荐
已经有2人回复
-
海勃原辅料助力银屑病一线外用制剂开发
已经有0人回复
-
药理学论文润色/翻译怎么收费?
已经有218人回复
-
请教执业药师报考的一些问题
已经有4人回复
-
二乙烯基砜的合成路径
已经有4人回复
-
求一株[b]敲除MTAP(human)的HCT-116(人结肠癌细胞)/b]细胞
已经有0人回复
-
求助！求美国食品化学药典内容：FCC13【低聚果糖专论】
已经有0人回复
-
【2027博士申请】纳米药物递送方向
已经有5人回复
-
消耗微量API，便可预测早期研发阶段的HME工艺可行性
已经有0人回复
-
反应液中苯酐除去
已经有1人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- 质量标准的建立
已经有3人回复
- 质量标准建立设计方案
已经有3人回复
- 原研产品相关质量标准信息怎么查询啊？
已经有6人回复
- 阿立哌唑国外质量标准
已经有11人回复
- 求助凝胶剂质量检测标准
已经有3人回复
- 求助原研药品说明书及质量标准
已经有4人回复
- 求助各位一个关于质量标准中有关物质的问题
已经有19人回复
- 卵磷脂质量的国际标准
已经有7人回复
- 化工原料的质量标准
已经有5人回复
- 药典质量标准翻译
已经有4人回复
- 塞来昔布原料质量标准
已经有123人回复
- 求助关于质量标准有关物质问题
已经有15人回复
- 【求助】关于质量标准研究中液相色谱峰对称性问题
已经有16人回复
- 【求助】卵磷脂的质量标准
已经有3人回复
- 【交流】国家药典中的质量标准是怎么建立起来的？
已经有18人回复
- 【求助】US EPA 制定的土壤重金属的环境质量标准
已经有10人回复
mxx7456
新虫 (小有名气)
- 应助: 22 (小学生)
- 金币: 836.9
- 帖子: 113
- 在线: 37.5小时
- 虫号: 671698
- 注册: 2008-12-10
- 性别: MM
- 专业: 中药质量评价
4楼2015-05-18 17:18:02
xdx1984
木虫 (正式写手)
- 应助: 22 (小学生)
- 金币: 3687.7
- 红花: 12
- 帖子: 474
- 在线: 195.9小时
- 虫号: 847461
- 注册: 2009-09-14
- 性别: GG
- 专业: 药物分析
2楼2015-05-18 13:54:22
【答案】应助回帖
★ ★
感谢参与，应助指数 +1
mm1988: 金币+2, ★★★很有帮助, USP38这是在哪里找的，美国药典论坛吗？如果是能不能教教我怎么查，注册了账号不会查，好惭愧 2015-05-19 09:41:22
感谢参与，应助指数 +1
mm1988: 金币+2, ★★★很有帮助, USP38这是在哪里找的，美国药典论坛吗？如果是能不能教教我怎么查，注册了账号不会查，好惭愧 2015-05-19 09:41:22
|
USP38 Iohexol Injection DEFINITION Iohexol Injection is a sterile solution of Iohexol in Water for Injection. It contains NLT 95.0% and NMT 105.0% of the labeled amount of iohexol (C19H26I3N3O9) as organically bound iodine. It may contain small amounts of suitable buffers and Edetate Calcium Disodium as a stabilizer. Iohexol Injection intended for intravascular or intrathecal use contains no antimicrobial agents. IDENTIFICATION • A. The retention times of the major peaks of the Sample solution correspond to those of the System suitability solution, as obtained in the test for Organic Impurities. ASSAY • Procedure Sample: A volume of Injection equivalent to 300 mg of iodine Analysis: Transfer the Sample to a glass-stoppered, 250-mL conical flask. Add 25 mL of 1.25 N sodium hydroxide and 500 mg of powdered zinc, connect the flask to a reflux condenser, and reflux the solution for 1 h. Cool the flask to room temperature, rinse the condenser with 20 mL of water, disconnect the flask from the condenser, and filter the mixture. Rinse the flask and the filter thoroughly with small portions of water, adding the rinsings to the filtrate. Add 5 mL of glacial acetic acid, and titrate with 0.1 N silver nitrate VS. Each mL of 0.1 N silver nitrate is equivalent to 27.37 mg of C19H26I3N3O9. Acceptance criteria: 95.0%–105.0% IMPURITIES • Organic Impurities Solution A: Acetonitrile Solution B: Water Mobile phase: The percentage of Solution A increases from 1% to 13% at a rate of 0.2%/min. System suitability solution: 1.5 mg/mL, 0.0075 mg/mL, and 0.0069 mg/mL each of USP Iohexol RS, USP Iohexol Related Compound A RS, and USP Iohexol Related Compound C RS in water Sample solution: 1.5 mg/mL of Iohexol Chromatographic system (See Chromatography 621, System Suitability.) Mode: LC Detector: UV 254 nm Column: 4.6-mm × 25-cm stainless steel column; packing L1 Flow rate: 1.0 mL/min Injection volume: 10 µL System suitability Sample: System suitability solution [Note—The relative retention times for the exo-isomer of iohexol and the O-alkylated compounds are 1.0 and between 1.1 and 1.4, respectively. ] [Note—The peak area of iohexol related compound C is 0.5% ± 0.1% compared to the total area of all the peaks in the chromatogram. ] Suitability requirements Resolution: NLT 20.0 between iohexol related compound A and iohexol related compound C Analysis Sample: Sample solution Excluding peaks with retention times between 0.84 (relative to the endo-isomer of iohexol, which is the first main peak) and 1.0, calculate the percentage of O-alkylated compounds and any other individual impurity peak, in the portion of Iohexol taken: Result = (rU/rT) × 100 rU = = peak response of each impurity rT = = sum of all the peak responses Acceptance criteria Individual impurity: NMT 0.6% of O-alkylated compounds; NMT 0.1% of any other individual impurity Total impurities: NMT 0.3%, excluding O-alkylated compounds SPECIFIC TESTS • Bacterial Endotoxins Test 85: NMT 0.2 USP Endotoxin Unit per 50 mg of iodine • pH 791: 6.8–7.7 • Particulate Matter in Injections 788: The Injection labeled for intrathecal use meets the requirements for small-volume injections. • Free Iodide: Transfer 5.0 mL of Injection to a suitable container, add 20 mL of water, and titrate with 0.001 N silver nitrate VS using a silver electrode in combination with an appropriate reference electrode. Each mL of 0.001 N silver nitrate is equivalent to 0.1269 mg of iodine. Acceptance criteria: NMT 0.02%, based on the content of iohexol • Injections 1: Meets the requirements ADDITIONAL REQUIREMENTS • Packaging and Storage: Preserve Injection intended for intravascular or intrathecal use in single-dose or multiple-dose plastic or Type I glass containers. Store at controlled room temperature, protected from light. Do not freeze. • Labeling: Label containers of Injection to direct the user to discard any unused portion. The labeling states also that it is not to be used if it is discolored or contains a precipitate. Label it also to state its routes of administration. When the specific dose strength is not intended for intrathecal use, label it to indicate “serious injury can occur if given by intrathecal route”. • USP Reference Standards 11 USP Endotoxin RS USP Iohexol RS USP Iohexol Related Compound A RS 5-(Acetylamino)-N,N¢-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide. USP Iohexol Related Compound C RS N,N¢-Bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide. |
3楼2015-05-18 16:43:55
5楼2015-05-19 09:15:37
